Haff disease: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
Line 15: Line 15:
}}
}}
{{Haff disease}}
{{Haff disease}}
{{CMG}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [https://www.wikidoc.org/index.php/User:Hassan_M M. Hassan, M.B.B.S]


==[[Haff disease overview|Overview]]==
==[[Haff disease overview|Overview]]==
Line 30: Line 30:
Haff disease is known to cause '''rhabdomyolysis''', and therefore, it should be differentiated from other causes of rhabdomyolysis.  There are numerous etiologies of rhabdomyolysis and they may be categorized based on the physical, non-physical and genetic factors.
Haff disease is known to cause '''rhabdomyolysis''', and therefore, it should be differentiated from other causes of rhabdomyolysis.  There are numerous etiologies of rhabdomyolysis and they may be categorized based on the physical, non-physical and genetic factors.


=== Physical factors ===
===Physical factors===
* Trauma
* Excessive muscular activity
* Status epilepticus
* High-grade fever
* Heat stroke
* Electric shock


=== Non-physical factors ===
*Trauma
* Medication (e.g., anti-retroviral, anti-histamine, anti-psychotics, antidepressants, and statins)
*Excessive muscular activity
* Infection (bacterial, and viral)
*Status epilepticus
* Drugs (e.g., alcohol, heroin, cocaine, methamphetamine, ecstasy, and LSD)
*High-grade fever
* Electrolyte abnormalities (e.g., hypokalemia, hypophosphatemia, hyponatremia, and hypernatremia)
*Heat stroke
*Electric shock


=== Genetic factors ===
===Non-physical factors===
* Autoimmune diseases (e.g., polymyositis and dermatomyositis)
 
* Metabolic diseases (e.g., diabetes, thyroid dysfunction, primary hyperaldosteronism, primary adrenal insufficiency, central diabetes insipidus, postpartum hypernatremia, and pituitary dysfunction).
*Medication (e.g., anti-retroviral, anti-histamine, anti-psychotics, antidepressants, and statins)
* Inherited conditions (e.g., glycogen storage disorders, fatty acid oxidation disorders, mitochondrial myopathies, muscular dystrophies, and RYR1- related myopathies)
*Infection (bacterial, and viral)
*Drugs (e.g., alcohol, heroin, cocaine, methamphetamine, ecstasy, and LSD)
*Electrolyte abnormalities (e.g., hypokalemia, hypophosphatemia, hyponatremia, and hypernatremia)
 
===Genetic factors===
 
*Autoimmune diseases (e.g., polymyositis and dermatomyositis)
*Metabolic diseases (e.g., diabetes, thyroid dysfunction, primary hyperaldosteronism, primary adrenal insufficiency, central diabetes insipidus, postpartum hypernatremia, and pituitary dysfunction).
*Inherited conditions (e.g., glycogen storage disorders, fatty acid oxidation disorders, mitochondrial myopathies, muscular dystrophies, and RYR1- related myopathies)


==[[Haff disease epidemiology and demographics|Epidemiology and Demographics]]==
==[[Haff disease epidemiology and demographics|Epidemiology and Demographics]]==
Line 60: Line 63:
==Treatment==
==Treatment==
[[Haff disease medical therapy|Medical Therapy]] | [[Haff disease surgery|Surgery]] | [[Haff disease primary prevention|Primary Prevention]] | [[Haff disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Haff disease future or investigational therapies|Future or Investigational Therapies]]
[[Haff disease medical therapy|Medical Therapy]] | [[Haff disease surgery|Surgery]] | [[Haff disease primary prevention|Primary Prevention]] | [[Haff disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Haff disease future or investigational therapies|Future or Investigational Therapies]]





Revision as of 02:59, 26 March 2022

Haff disease
Haff disease was first described in the location of Königsberg/Frisches Haff[1]
ICD-9 985.1
DiseasesDB 33568

Haff disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Haff disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Haff disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Haff disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Haff disease

CDC on Haff disease

Haff disease in the news

Blogs on Haff disease

Directions to Hospitals Treating Haff disease

Risk calculators and risk factors for Haff disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Haff disease from other Diseases

[2]

Haff disease is known to cause rhabdomyolysis, and therefore, it should be differentiated from other causes of rhabdomyolysis. There are numerous etiologies of rhabdomyolysis and they may be categorized based on the physical, non-physical and genetic factors.

Physical factors

  • Trauma
  • Excessive muscular activity
  • Status epilepticus
  • High-grade fever
  • Heat stroke
  • Electric shock

Non-physical factors

  • Medication (e.g., anti-retroviral, anti-histamine, anti-psychotics, antidepressants, and statins)
  • Infection (bacterial, and viral)
  • Drugs (e.g., alcohol, heroin, cocaine, methamphetamine, ecstasy, and LSD)
  • Electrolyte abnormalities (e.g., hypokalemia, hypophosphatemia, hyponatremia, and hypernatremia)

Genetic factors

  • Autoimmune diseases (e.g., polymyositis and dermatomyositis)
  • Metabolic diseases (e.g., diabetes, thyroid dysfunction, primary hyperaldosteronism, primary adrenal insufficiency, central diabetes insipidus, postpartum hypernatremia, and pituitary dysfunction).
  • Inherited conditions (e.g., glycogen storage disorders, fatty acid oxidation disorders, mitochondrial myopathies, muscular dystrophies, and RYR1- related myopathies)

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Ultrasound | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies


Template:WikiDoc Sources

References

  1. Template:Dorlands
  2. Nance JR, Mammen AL (2015). "Diagnostic evaluation of rhabdomyolysis". Muscle Nerve. 51 (6): 793–810. doi:10.1002/mus.24606. PMC 4437836. PMID 25678154.


Template:WikiDoc Sources